Vajihe Ghorbanzadeh

Dr. Vajihe Ghorbanzadeh


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2018 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
NRneda Roshanravan
neda Roshanravan
PAparina asgharian
parina asgharian
HDHassan Dariushnejad
Hassan Dariushnejad
NANaimeh Mesri Alamdari
Naimeh Mesri Alamdari
BMBehzad Mansoori
Behzad Mansoori
AOAlireza Ostadrahimi
Alireza Ostadrahimi
Purpose: Pancreatic adenocarcinoma has a high prevalence all over the world. Most of the therapeutic approaches failed as a result of tumor invasion and rapid metastasis. Several natural plants have been shown to have promising therapeutic effects. Thus, the aim of this study was to investigate the cytotoxic activity of Eryngium billardieri against PANC-1 cancer cell lines. Methods: Dimethylthiazole diphenyltetrazolium bromide assay (MTT assay) and flow cytometry were used to assess the cytotoxicity of E. billardieri extracts against PANC-1 cancer cell lines. Quantitative Polymerase Chain Reaction (qPCR) was conducted to investigate the expression levels of Bcl2- associated X protein (BAX) and cyclin D1. Results: The results of the MTT assay showed that E. billardieri extracts had cytotoxic effects on PANC- 1 cancer cell lines. Moreover, the findings from the gene expression confirmed the over expression of Bax, and under expression of cyclin D1 following treatment with dichloromethane (DCM) and n-hexane (n- hex) extracts in cancer cells (P < 0.05). Interestingly, the flow cytometry results showed that DCM and n- hex extracts of E. billardieri induced apoptosis in PANC- 1 cancer cell lines. Conclusion: The results of this study demonstrated that DCM and n- hex extracts of E. billardieri significantly induce apoptosis by increasing Bax and decreasing cyclin D1 mRNA expression. Therefore, E. billardieri may be regarded as a novel approach for treatment of pancreatic cancer as a result of its promising apoptotic and cytotoxic properties.

19 April 2016 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
VGVajihe Ghorbanzadeh
Vajihe Ghorbanzadeh
MMM. Mohammadi
M. Mohammadi
HDHassan Dariushnejad
Hassan Dariushnejad
LCL. Chodari
L. Chodari
GMG. Mohaddes
G. Mohaddes

10 August 2023 in BioFactors
Verified
Journal Article
Closed access
ZSZeynab Sarlak
Zeynab Sarlak
AEAkram Eidi
Akram Eidi
VGVajihe Ghorbanzadeh
Vajihe Ghorbanzadeh
MMMehrnoush Moghaddasi
Mehrnoush Moghaddasi
PMPejman Mortazavi
Pejman Mortazavi

17 October 2019 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
PHPejman Hashemzadeh
Pejman Hashemzadeh
VGVajihe Ghorbanzadeh
Vajihe Ghorbanzadeh
HLHamed Esmaeil Lashgarian
Hamed Esmaeil Lashgarian
FKFarnaz Kheirandish
Farnaz Kheirandish
HDHassan Dariushnejad
Hassan Dariushnejad

1 January 2022 in Microvascular Research
Verified
Journal Article
Closed access
VGVajihe Ghorbanzadeh
Vajihe Ghorbanzadeh
BPBagher Pourheydar
Bagher Pourheydar
HDHassan Dariushnejad
Hassan Dariushnejad
AGAtaollah Ghalibafsabbaghi
Ataollah Ghalibafsabbaghi
LCLeila Chodari
Leila Chodari

9 March 2019 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
SFSafar Farajnia
Safar Farajnia
VGVajihe Ghorbanzadeh
Vajihe Ghorbanzadeh
HDHassan Dariushnejad
Hassan Dariushnejad